NovaBridge Biosciences (NBP) Tax Provisions (2020 - 2024)
NovaBridge Biosciences (NBP) posted quarterly Tax Provisions of -$8.2 million for Q4 2024, down 344.31% on a QoQ basis from -$1.8 million in Q4 2020.
NovaBridge Biosciences (NBP) Tax Provisions (2020 - 2024) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Tax Provisions for 2 consecutive years, with -$8.2 million the latest figure, recorded in Q4 2024.
- Quarterly Tax Provisions changed N/A year-over-year to -$8.2 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$10.0 million (changed N/A YoY) and the FY2024 annual result came in at -$8.2 million, up 39.55% from the prior year.
- Tax Provisions fell to -$8.2 million in Q4 2024 per NBP's latest filing, from -$1.8 million in the prior quarter.
- Over the last five years, Tax Provisions for NBP reached as high as -$1.8 million in Q4 2020 and fell as low as -$8.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -8.20 Mn |
| Dec 31, 2020 | -1.85 Mn |